Clinical Implications of HER-2/Neu in GI Cancers and Beyond

Education Session
Speaker: Daniel V.T. Catenacci, MD
Meeting: 2021 ASCO Annual Meeting
Session Title: ASCO/American Association for Cancer Research (AACR) Joint Session: HER-2/Neu Alterations–Using Biology to Drive Therapeutic Options in Cancers of the Breast, Gut, and Beyond
Track: Breast Cancer

Other videos in this session

Education Session
Speaker: Lori J. Pierce, MD, FASTRO, FASCO
Session Title: ASCO/American Association for Cancer Research (AACR) Joint Session: HER-2/Neu Alterations–Using Biology to Drive Therapeutic Options in Cancers of the Breast, Gut, and Beyond
Meeting: 2021 ASCO Annual Meeting
Education Session
Speaker: Dennis J. Slamon, MD, PhD
Session Title: ASCO/American Association for Cancer Research (AACR) Joint Session: HER-2/Neu Alterations–Using Biology to Drive Therapeutic Options in Cancers of the Breast, Gut, and Beyond
Meeting: 2021 ASCO Annual Meeting
Education Session
Speaker: Panel Discussion
Session Title: ASCO/American Association for Cancer Research (AACR) Joint Session: HER-2/Neu Alterations–Using Biology to Drive Therapeutic Options in Cancers of the Breast, Gut, and Beyond
Meeting: 2021 ASCO Annual Meeting
Education Session
Speaker: Patricia LoRusso, DO
Session Title: ASCO/American Association for Cancer Research (AACR) Joint Session: HER-2/Neu Alterations–Using Biology to Drive Therapeutic Options in Cancers of the Breast, Gut, and Beyond
Meeting: 2021 ASCO Annual Meeting

This site is intended for healthcare professionals in Europe and Japan only.

The selection of ASCO content on this site was made by the ASCO Publication and Education teams. Springer Healthcare selected the experts for interview. All content is made available solely for educational and informational purposes and personal use only.

© 2023 American Society of Clinical Oncology (ASCO®). All Rights Reserved.

This program is supported by an educational grant from Daiichi Sankyo and brought to you by Springer Healthcare | Contact Us | Privacy Policy

Before you go....

We'd love your feedback!

Your feedback will help guide us in the next phase of this program. Please take a few minutes (estimated 2 minutes) to answer the following 6 questions.